Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/8/2019
SIETES contiene 92796 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. A nested case-control study. JAMA Intern Med 2019:24 de junio. [Ref.ID 103160]
2.Enlace a cita original Cita con resumen
Schiek S, Hildebrandt K, Zube O, Bertsche T. Fall-risk-increasing adverse reactions - is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 2019;75:junio. [Ref.ID 103137]
3. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
4.
Ibañez C, Zara C. Observatori de consum de medicaments. Prescripció off-label d'antipsicòtics a l'RSB. e-farma RSB 2015;23:8-9. [Ref.ID 99062]
5. Cita con resumen
Borrell M, Clusa Gironella D. Una proposta per a la prescripció racional de neurolèptics. e-farma RSB 2015;23:5-7. [Ref.ID 99057]
6. Cita con resumen
Weeke P, Jensen A, Folke F, Gislason GH, Fosbol EL, Wissenberg M, Lippert FK, Christensen EF, Nielsen SL, Holm E, Kanters JK, Poulsen HE, Kober L, Torp-Pedersen C. Antipsychotics and associated risk of out-of-hospital cardiac arrest. Clin Pharmacol Ther 2014;96:490-7. [Ref.ID 97924]
7. Cita con resumen
8. Cita con resumen
Chang C, Gershwin ME. Drug-induced lupus erythematosus. Incidence, management and prevention. Drug Saf 2011;34:357-74. [Ref.ID 90404]
9.
Anónimo. Neuroleptiques: troubles de la déglutition. Prescrire 2010;30:746-8. [Ref.ID 89217]
10. Cita con resumen
Anónimo. Syndrome des jambes sans repos d'origine médicamenteuse. Prescrire 2010;30:270-2. [Ref.ID 88321]
11.Enlace a cita original
Peyrière H, Roux C, Ferard C, Deleau N, Kreft-Jais C, Hillaire-Buys D, Boulenger J-P, Blayac J-P, The French Network of the Pharmacovigilance Centers. Antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database. Pharmacoepidemiol Drug Saf 2009;18:948-55. [Ref.ID 86840]
12.Enlace a cita original
Carvajal A, García del Pozo J, de Abajo FJ. Utilización de antipsicóticos en España, 1992-2006. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2009:1-8. [Ref.ID 86458]
13.Tiene citas relacionadas
Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006;63:1079-89. [Ref.ID 78467]
14.Tiene citas relacionadas Cita con resumen
Hopkins J. Newer antipsychotic drugs are no better than older ones, study finds. BMJ 2006;333:771. [Ref.ID 78308]
16.
Anónimo. Antipsicóticos: ¿típicos o atípicos?. PAM 2004;28:663-700. [Ref.ID 71663]
17. Cita con resumen
Leucht S, Wahlbeck K, Hamann J, Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 2003;361:1581-9. [Ref.ID 66022]
18.
Madhusoodanan S, Bogunovic OJ, Moise D, Brenner R, Markowitz S, Sotelo J. Hyponatraemia associated with psychotropic medications: a review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev 2002;21:17-29. [Ref.ID 62070]
19. Cita con resumen
Bagheri H, Michel F, Lapeyre-Mestre M, Lagier E, Cambus JP, Valdiguié P, Montastruc J-L. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol 2000;50:479-84. [Ref.ID 53798]
20. Cita con resumen
Anónimo. Atypical neuroleptics. Neuroleptic malignant syndrome. Denmark. WHO Pharmaceuticals Newsletter 2000;2:10. [Ref.ID 53158]
Seleccionar todas
 
 1 a 20 de 32 siguiente >>